These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34277392)

  • 1. Identification of Flap Endonuclease 1 With Diagnostic and Prognostic Value in Breast Cancer.
    Wu M; Zhang P; Wang P; Fang Z; Zhu Y
    Front Oncol; 2021; 11():603114. PubMed ID: 34277392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flap endonuclease 1 (FEN1) as a novel diagnostic and prognostic biomarker for gastric cancer.
    Zhao E; Zhou C; Chen S
    Clin Res Hepatol Gastroenterol; 2021 Jan; 45(1):101455. PubMed ID: 32505732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Upregulation of FEN1 Is Associated with the Tumor Progression and Prognosis of Hepatocellular Carcinoma.
    Zhang Y; Liu X; Liu L; Chen J; Hu Q; Shen S; Zhou Y; Chen S; Xue C; Cui G; Yu Z
    Dis Markers; 2020; 2020():2514090. PubMed ID: 32399086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative analysis of prognostic value and immune infiltration of spindle and kinetochore-associated family members in breast cancer.
    Ding J; He X; Wang J; Cao G; Chen S; Yuan L; Chen B; Xiong M
    Bioengineered; 2021 Dec; 12(2):10905-10923. PubMed ID: 34845974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FEN1 is a prognostic biomarker for ER+ breast cancer and associated with tamoxifen resistance through the ERĪ±/cyclin D1/Rb axis.
    Xu L; Shen JM; Qu JL; Song N; Che XF; Hou KZ; Shi J; Zhao L; Shi S; Liu YP; Qu XJ; Teng YE
    Ann Transl Med; 2021 Feb; 9(3):258. PubMed ID: 33708885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive analysis of the diagnostic and prognostic value associated with the
    Yan L; He J; Liao X; Liang T; Zhu J; Wei W; He Y; Zhou X; Peng T
    Gland Surg; 2022 Feb; 11(2):389-411. PubMed ID: 35284318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expressions and prognostic values of the
    Liu ZL; Bi XW; Liu PP; Lei DX; Wang Y; Li ZM; Jiang WQ; Xia Y
    Cancer Manag Res; 2018; 10():3521-3532. PubMed ID: 30271201
    [No Abstract]   [Full Text] [Related]  

  • 8. Increased
    Liu J; He Y; Li C; Zhou R; Yuan Q; Hou J; Wu G
    Transl Cancer Res; 2021 Sep; 10(9):4009-4019. PubMed ID: 35116699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulated mRNA Expression of ZNF385B Is an Independent Predictor of Breast Cancer.
    Yan N; Liu C; Tian F; Wang L; Wang Y; Yang Z; Jiao Y; He M
    Int J Genomics; 2021; 2021():4301802. PubMed ID: 33614780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Prognostic Biomarkers and Molecular Targets Among JAK Family in Breast Cancer.
    Liu F; Wu H
    J Inflamm Res; 2021; 14():97-114. PubMed ID: 33469338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and Clinical Significance of Origin Recognition Complex Subunit 6 in Breast Cancer - A Comprehensive Bioinformatics Analysis.
    Chen S; Jin Z; Xin L; Lv L; Zhang X; Gong Y; Liu J
    Int J Gen Med; 2021; 14():9733-9745. PubMed ID: 34934348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulated ZNF132 predicts unfavorable outcomes in breast Cancer via Hypermethylation modification.
    Liu Z; Liu J; Liu R; Xue M; Zhang W; Zhao X; Zhu J; Xia P
    BMC Cancer; 2021 Apr; 21(1):367. PubMed ID: 33827486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble POSTN is a novel biomarker complementing CA153 and CEA for breast cancer diagnosis and metastasis prediction.
    Jia L; Li G; Ma N; Zhang A; Zhou Y; Ren L; Dong D
    BMC Cancer; 2022 Jul; 22(1):760. PubMed ID: 35831854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulation of serum miR-1204 and its potential as a biomarker for the diagnosis and prognosis of breast cancer.
    Han S; Li P; Wang D; Yan H
    Rev Assoc Med Bras (1992); 2020 Jun; 66(6):732-736. PubMed ID: 32696863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GLUT1/3/4 as novel biomarkers for the prognosis of human breast cancer.
    Zeng K; Ju G; Wang H; Huang J
    Transl Cancer Res; 2020 Apr; 9(4):2363-2377. PubMed ID: 35117597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating lncRNA H19 in plasma as a novel biomarker for breast cancer.
    Zhang K; Luo Z; Zhang Y; Zhang L; Wu L; Liu L; Yang J; Song X; Liu J
    Cancer Biomark; 2016 Jun; 17(2):187-94. PubMed ID: 27540977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and Prognostic Significance of the MMP Family Molecules in Bladder Cancer.
    Shen C; Da L; Wu Z; Wang Y; Gao S; Tian D; Hu H
    Comb Chem High Throughput Screen; 2021; 24(8):1183-1196. PubMed ID: 32940175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of Potential Therapeutic Targets Among CXC Chemokines in Breast Tumor Microenvironment Using Integrative Bioinformatics Analysis.
    Chen E; Qin X; Peng K; Xu X; Li W; Cheng X; Tang C; Cui Y; Wang Z; Liu T
    Cell Physiol Biochem; 2018; 45(5):1731-1746. PubMed ID: 29495008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of endothelial selectin as a potential prognostic marker in breast cancer.
    Zhang W; Zuo Z; Huang X; Liu J; Jin G; Su D
    Oncol Lett; 2018 Jun; 15(6):9908-9916. PubMed ID: 29928363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic analysis of the expression and prognosis relevance of FBXO family reveals the significance of FBXO1 in human breast cancer.
    Liu Y; Pan B; Qu W; Cao Y; Li J; Zhao H
    Cancer Cell Int; 2021 Feb; 21(1):130. PubMed ID: 33622332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.